Indications for Use
The ATS Open Pivot Heart Valve is intended for the replacement of diseased, damaged or malfunctioning heart valves. ATS Open Pivot Heart Valves must be prescribed and ordered by a licensed physician.
Contraindications
There are no known contraindications to heart valve replacement with an ATS Open Pivot Heart Valve for patients who have been determined to be a candidate for mechanical heart valve replacement.
References
1. Kelly S, et al. A three-dimensional analysis of flow in the pivot regions of an ATS bileaflet valve. Int J Artif Organs 1999; 22:754-763.
2. Emery R, et al. The Initial United States Experience With the ATS Mechanical Cardiac Valve Prosthesis. The Heart Surgery Forum. 2001; 4(4):346-353.
3. Emery R, et al. Five-Year Follow Up of the ATS Mechanical Heart Valve. J Heart Valve Dis. 2004; 13(2):231-8.
4. ATS Medical Inc., Pre-market Approval Application – Summary of Safety and Effectiveness: 2000. Washington, D.C.; U.S. Food and Drug Administration. 2000. P990046.
5. Echevarria J, et al. Clinical and Hemodynamic Performance of the ATS Heart Vavle Prosthesis (AP Series) in the Small Aortic Root. Abstract presented at: 15th World Congress of the World Society of Cardiothoracic Surgeons, 1999.
6. Jazayeri S, et al. Clinical Experience and Doppler Echocardiographic Assessment of the First One Hundred ATS AP (Advanced Perfomance) Prosthetic Valve in the Aortic Position. J Heart Valve Disease. 2003; 12(2):628-634.
7. Karpuz H, et al. Doppler Echocardiographic Assessment of the New ATS Medical Prosthetic Valve in the Aortic Position. Am J Card Imaging. 1996; 10(4):254-60.
8. Thomson H, et al. Haemodynamics and left ventricular mass regression: a comparison of the stentless, stented, and mechanical aortic valve replacement. Eur J Cardio-thorac Surg. 1998; 13(5):572-575.
9. Autschbach R, et al. Prospectively Randomized Comparison of Different Mechanical Aortic Valves. Circulation 2000; 102[suppl III]lIII-1-III-4.
10. Shiono M, et al. Multi-institutional experience of the ATS Open Pivot bileaflet valve in Japan. Ann Thorac Cardiovasc Surg. 1996; 2(1):51-8.
11. Krian A. Clinical results of a large series of ATS valve implants. In: Krian A, Matloff JM, Nicoloff DM, eds. Advancing the Technology of Bileaflet Mechanical Heart Valves: Springer Verlag; 1998:53-71.
12. Sezai A, et al. Evaluation of valve sound and its effects on ATS prosthetic valves in patient's quality of life. Ann Thorac Surg. 2000; 69:507-512.
13. Hata M, et al. Mid-term results of ATS Open Pivot Bileaflet mechanical prosthetic heart valve. Ann Thorac Cardiovasc Surg. 2000; 6(1):34-38.
Federal Law restricts this device to sale by or on the order of a physician or properly licensed practitioner. Refer to the Instructions For Use packaged with each valve for a complete listing of warnings and precautions. The ATS Open Pivot Heart Valve is indicated for the replacement of diseased, damaged, or malfunctioning native or prosthetic aortic or mitral valves. The ATS Open Pivot Heart Valve is contraindicated in patients unable to tolerate anticoagulation therapy. Adverse events potentially associated with the use of prosthetic heart valves include: cardiac arrhythmias, death, leaflet entrapment (impingement), endocarditis, hemolysis, anticoagulant-related hemorrhage, transvalvular or perivalvular leak, prosthesis thrombosis, structural deterioration, valve thromboembolism.
Manufactured under licensed U.S. Patent 4,692,165. United States Patent Number No. 5,354,330, European Patent Number 0541215 and German Patent No. P69214597.4. ATS Medical and ATS Open Pivot are registered trademarks of ATS Medical, Inc. All rights reserved. ©2006 ATS Medical, Inc.